Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This is a blinded study in adult patients with PAH evaluating the relative effects of sildenafil on mortality when administered at the three doses (80 mg, 20 mg or 5 mg, all three times per day [TID]). In addition, the relative effects on clinical worsening and 6-minute walking distance (6MWD) will be assessed.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Subjects ≥ 18 <75 years of age with any of the following conditions:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
385 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal